Warning: The NCBI web site requires JavaScript to function. more...
Vpu serine 52 dependent counteraction of tetherin is required for HIV-1 replication in macrophages, but not in ex vivo human lymphoid tissue.
Schindler M, Rajan D, Banning C, Wimmer P, Koppensteiner H, Iwanski A, Specht A, Sauter D, Dobner T, Kirchhoff F.
Retrovirology. 2010 Jan 15;7:1.
Related citations
Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism.
Douglas JL, Viswanathan K, McCarroll MN, Gustin JK, Früh K, Moses AV.
J Virol. 2009 Aug;83(16):7931-47. Epub 2009 Jun 10.
The formation of cysteine-linked dimers of BST-2/tetherin is important for inhibition of HIV-1 virus release but not for sensitivity to Vpu.
Andrew AJ, Miyagi E, Kao S, Strebel K.
Retrovirology. 2009 Sep 8;6:80.
Antagonism of CD317 restriction of human immunodeficiency virus type 1 (HIV-1) particle release and depletion of CD317 are separable activities of HIV-1 Vpu.
Goffinet C, Homann S, Ambiel I, Tibroni N, Rupp D, Keppler OT, Fackler OT.
J Virol. 2010 Apr;84(8):4089-94. Epub 2010 Feb 10.
HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation.
Mangeat B, Gers-Huber G, Lehmann M, Zufferey M, Luban J, Piguet V.
PLoS Pathog. 2009 Sep;5(9):e1000574. Epub 2009 Sep 4.
Cell-cell spread of human immunodeficiency virus type 1 overcomes tetherin/BST-2-mediated restriction in T cells.
Jolly C, Booth NJ, Neil SJ.
J Virol. 2010 Dec;84(23):12185-99. Epub 2010 Sep 22.
Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment.
Dubé M, Roy BB, Guiot-Guillain P, Binette J, Mercier J, Chiasson A, Cohen EA.
PLoS Pathog. 2010 Apr 8;6(4):e1000856.
Anti-tetherin activities in Vpu-expressing primate lentiviruses.
Yang SJ, Lopez LA, Hauser H, Exline CM, Haworth KG, Cannon PM.
Retrovirology. 2010 Feb 18;7:13.
CAML does not modulate tetherin-mediated restriction of HIV-1 particle release.
Ali MS, Hammonds J, Ding L, Spearman P.
PLoS One. 2010 Feb 2;5(2):e9005.
Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking.
Mitchell RS, Katsura C, Skasko MA, Fitzpatrick K, Lau D, Ruiz A, Stephens EB, Margottin-Goguet F, Benarous R, Guatelli JC.
PLoS Pathog. 2009 May;5(5):e1000450. Epub 2009 May 29.
Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion.
Gupta RK, Hué S, Schaller T, Verschoor E, Pillay D, Towers GJ.
PLoS Pathog. 2009 May;5(5):e1000443. Epub 2009 May 22.
Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion.
Miyagi E, Andrew AJ, Kao S, Strebel K.
Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2868-73. Epub 2009 Feb 5.
Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2.
Jia B, Serra-Moreno R, Neidermyer W, Rahmberg A, Mackey J, Fofana IB, Johnson WE, Westmoreland S, Evans DT.
PLoS Pathog. 2009 May;5(5):e1000429. Epub 2009 May 15.
The ESCRT-0 component HRS is required for HIV-1 Vpu-mediated BST-2/tetherin down-regulation.
Janvier K, Pelchen-Matthews A, Renaud JB, Caillet M, Marsh M, Berlioz-Torrent C.
PLoS Pathog. 2011 Feb 3;7(2):e1001265.
Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein.
Vigan R, Neil SJ.
J Virol. 2010 Dec;84(24):12958-70. Epub 2010 Oct 6.
Regulation of virus release by the macrophage-tropic human immunodeficiency virus type 1 AD8 isolate is redundant and can be controlled by either Vpu or Env.
Schubert U, Bour S, Willey RL, Strebel K.
J Virol. 1999 Feb;73(2):887-96.
Polarity changes in the transmembrane domain core of HIV-1 Vpu inhibits its anti-tetherin activity.
Lv M, Wang J, Wang X, Zuo T, Zhu Y, Kong W, Yu X.
PLoS One. 2011;6(6):e20890. Epub 2011 Jun 2.
HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor.
Goffinet C, Allespach I, Homann S, Tervo HM, Habermann A, Rupp D, Oberbremer L, Kern C, Tibroni N, Welsch S, Krijnse-Locker J, Banting G, Kräusslich HG, Fackler OT, Keppler OT.
Cell Host Microbe. 2009 Mar 19;5(3):285-97.
Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes.
Schubert U, Clouse KA, Strebel K.
J Virol. 1995 Dec;69(12):7699-711.
The presence of the casein kinase II phosphorylation sites of Vpu enhances the CD4(+) T cell loss caused by the simian-human immunodeficiency virus SHIV(KU-lbMC33) in pig-tailed macaques.
Singh DK, Griffin DM, Pacyniak E, Jackson M, Werle MJ, Wisdom B, Sun F, Hout DR, Pinson DM, Gunderson RS, Powers MF, Wong SW, Stephens EB.
Virology. 2003 Sep 1;313(2):435-51.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on